Central VetPharma Consultancy ApS: Financial statements 2023
CVR: 38773984
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Central VetPharma Consultancy ApS (CVR 38773984) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,359,512 and a net result of DKK 803,625 compared with DKK -97,167 the year before. That is a decrease of 3.4% compared with the year before. Equity in the 2023 report amounted to DKK 4,119,265. The solvency ratio was 92.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,359,512
- Profit/Loss
- DKK 803,625
- Equity
- DKK 4,119,265
- Total Assets
- DKK 4,442,678
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.4M | 804K | 4.1M | 1 |
| 2022 | - | 1.4M | -97K | 3.4M | 1 |
| 2021 | - | 1.3M | 577K | 3.6M | 1 |
| 2020 | - | 1.5M | 1M | 3.2M | - |
| 2019 | - | 1.8M | 1M | 2.3M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Central VetPharma Consultancy ApS has published its annual report for 2022. Gross profit came to DKK 1,407,207, and the net result was DKK -97,167.
About Central VetPharma Consultancy ApS
Central VetPharma Consultancy ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Elisabeth Houlberg Holm. The company is owned by Anja Elisabeth Houlberg Holm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,620,579 and a net result of DKK 719,033 compared with DKK 479,115 the year before. Equity in the 2025 report amounted to DKK 4,658,412.